Chiesi Group: Innovating Therapeutic Solutions for Respiratory Health and Rare Diseases
Chiesi Group is an international biopharmaceutical company focused on developing innovative therapeutic solutions in respiratory health, rare diseases, and neonatology. With a commitment to sustainability and community well-being, the company leverages 90 years of experience and a global research network to enhance patient lives. As a certified B Corp, Chiesi aligns its business success with social and environmental impact, aiming for Net Zero emissions by 2035. This dedication to research and development ensures that high-quality treatments remain accessible to those in need.